
    
      This is a phase 1b, multi-center, double-blind, randomized, vehicle-controlled study to be
      conducted in approximately 36 adult subjects with mild to moderate chronic plaque psoriasis.
      After obtaining informed consent, subjects will be randomized to active or vehicle treatment
      arms. Subjects will apply the study product (SB414 6% or Vehicle cream) twice daily to all
      affected areas of psoriasis on the trunk and/or extremities for 4 weeks.
    
  